Professor of Statistics and Epidemiology
- James Martin Fellow
Working in the Professorial Advisory Unit of The George Institute, Mark is also a Professor of Biostatistics at the University of Sydney, Professor of Statistics and Epidemiology at the University of Oxford and Adjunct Professor of Epidemiology at Johns Hopkins University.
He is the author of 400+ peer-reviewed publications and two text-books on statistical methods in medical research, one of which had its third edition published in January 2014. In the five year period from January 2009 to December 2013 he published 161 (>40% of his total) peer-reviewed publications, including seven in The Lancet, two in NEJM and one in JAMA. Three of his papers have over a thousand citations.
Mark has led four major international studies and directed the analytical research on three landmark collaborative studies, worldwide. His work on cardiovascular risk scores formed the basis of national guidelines in Scotland, and his recent work on kidney disease was used to produce new staging criteria for this disease. His total career grant awards are over $93 million from 39 successful applications.
He also has extensive experience in student teaching, postgraduate supervision and mentoring including 14 PhD and 19 MSc students successfully completed. He has given training workshops in Korea and Thailand, and has taught at least 25 other research training courses.
Mark served on the governing council of the Institute of Statisticians and the Royal Statistical Society (RSS) and is currently a fellow of the RSS, the European Society of Cardiology, the New York Academy of Medicine and the Royal Society of Medicine.
He has wide experience of development aid work in Africa and Asia, having undertaken 25 missions for aid agencies, such as the WHO. He has also assessed grants for six national medical research councils (including NHMRC) and served on the editorial boards of seven international journals.
Sex-specific relevance of diabetes to occlusive vascular and other mortality: Meta-analysis of individual data from 68 prospective studies with 77,000 deaths among 1 million adults
Lewington S. et al, (2018), The Lancet Diabetes and Endocrinology
The effect of socioeconomic disadvantage on prescription of guideline-recommended medications for patients with acute coronary syndrome: systematic review and meta-analysis
Hyun KK. et al, (2017), International Journal for Equity in Health, 16
Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial.
Wang X. et al, (2017), JAMA Neurol, 74, 1328 - 1335
Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON.
Jun M. et al, (2017), Diabetes care
Elevated blood pressure and risk of mitral regurgitation: A longitudinal cohort study of 5.5 million United Kingdom adults.
Rahimi K. et al, (2017), PLoS medicine, 14, e1002404 - e1002404